Catalyst Health Solutions Merger Investigated by the Securities Attorneys at The Briscoe Law Firm and Powers Taylor, LLP

DALLAS--(BUSINESS WIRE)--Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of Catalyst Health Solutions, Inc. (“Catalyst” or “CHSI”) (NASDAQ: CHSI) to SXC Health Solutions Corp. for shareholders. Under the proposed merger agreement, Catalyst shareholders will receive $28.00 in cash and 0.6606 shares of SXC stock for each share of Catalyst stock owned, which implies a purchase price of $81.02 per share.